Ming-han D. Cheng - Publications

Progranulin: A promising biomarker and therapeutic target for fibrotic diseases.

Journal: Acta pharmaceutica Sinica. B

Published: January 01, 2024

Melatonin ameliorates bleomycin-induced pulmonary fibrosis via activating NRF2 and inhibiting galectin-3 expression.

Journal: Acta pharmacologica Sinica

Published: July 01, 2022

Progranulin as a Potential Therapeutic Target in Immune-Mediated Diseases.

Journal: Journal of inflammation research

Published: September 16, 2021

Survival analysis of silicosis patients in Wuxi City

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: July 04, 2021

Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1.

Journal: Pharmacological research

Published: May 28, 2021

Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.

Journal: Journal of cellular physiology

Published: January 06, 2021

Sodium Houttuyfonate Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice.

Journal: Frontiers in pharmacology

Published: August 19, 2020

Natural products action on pathogenic cues in autoimmunity: Efficacy in systemic lupus erythematosus and rheumatoid arthritis as compared to classical treatments.

Journal: Pharmacological research

Published: March 23, 2020